Skip to main content
SpringerLink
Log in

Tenoxicam and Renal Function

  • Review Article
  • Drug Experience
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

The association of some nonsteroidal anti-inflammatory drugs (NSAIDs) with adverse effects on renal function has led to the need to systematically determine the risk of clinically relevant renal effects in patients treated with these drugs. Tenoxicam, an NSAID with established efficacy in the treatment of rheumatic diseases, has been studied in a variety of patient populations to evaluate its effects on renal function.

Investigational studies, up to 5 years’ duration, evaluated glomerular filtration rate, renal blood flow and tubular function. There was no evidence of clinically relevant renal toxicity in patients with normal renal function, in elderly patients with age-related renal function, or in patients with mild to moderate renal impairment. There was, however, one patient with pre-existing renal pathology, who experienced raised plasma creatinine after 5 years of treatment. These findings are supported by an analysis of urinary system adverse effects in clinical trials that included over 67 000 patients, 25% of whom were elderly. The prevalence of these events, 0.07%, was similar in patients in both age groups. The most common events were dysuria and renal pain.

Thus, patients treated long term with tenoxicam are at low risk for nephrotoxic effects. It is not recommended, however, that patients with severe pre-existing renal insufficiency receive tenoxicam.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Williams TF. Drugs and the elderly. Drug Info J 1985; 19: 397–400

    Google Scholar 

  2. del Favero A. Anti-inflammatory analgesics and drugs used in rheumatoid arthritis and gout. In: Dukes MNG, editor. Side effects of drugs annual. Vol 11. Amsterdam: Elsevier Science Publishers, 1987: 82–88

    Article  Google Scholar 

  3. Nilsen OG, Walstad RA, Eckert M, et al. Single and multiple dose pharmacokinetics of tenoxicam in the elderly. Eur J Clin Pharmacol 1988; 35: 563–6

    Article  PubMed  CAS  Google Scholar 

  4. Crevoisier C, Heizmann P, Forgo I, et al. Plasma tenoxicam concentrations after single and multiple oral doses. Eur J Drug Metab Pharmacokinet 1989; 14: 23–7

    Article  PubMed  CAS  Google Scholar 

  5. Horber FF, Guentert TW, Weidekamm E, et al. Pharmacokinetics of tenoxicam in patients with impaired renal function. Eur J Clin Pharmacol 1986; 29: 679–701

    Article  Google Scholar 

  6. Todd PA, Clissold SP. Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases. Drugs 1991; 41: 625–46

    Article  PubMed  CAS  Google Scholar 

  7. Heintz RCA, Guentert TW, Enrico JF, et al. Pharmacokinetics of tenoxicam in healthy human volunteers. Eur J Rheumatol Inflamm 1984; 7: 33–44

    PubMed  CAS  Google Scholar 

  8. Nilsen OG. Clinical pharmacokinetics of tenoxicam. Clin Pharmacokinet 1994; 26: 16–43

    Article  PubMed  CAS  Google Scholar 

  9. Freestone S, McAuslane JAN, Prescott LF. Effects of tenoxicam on renal function and the disposition of inulin and p-aminohippurate in healthy volunteers and patients with chronic renal failure. Br J Clin Pharmacol 1991; 32: 495–500

    Article  PubMed  CAS  Google Scholar 

  10. Giovannoni J-L, Ott H, de Torrenté A. Le tenoxicam et la fonction rénale. Schweiz Med Wochenschr 1990; 120: 793–7

    PubMed  CAS  Google Scholar 

  11. McAuslane JAN, Freestone S, Cowie J, et al. Tenoxicam: effect on renal function in normal man. Br J Clin Pharmacol 1987; 24: 277

    Google Scholar 

  12. Bird HA, Clarke AK, Fowler PD, et al. An assessment of tenoxicam, a nonsteroidal anti-inflammatory drug of long half-life, in patients with impaired renal function suffering from osteoarthritis or rheumatoid arthritis. Clin Rheumatol 1989; 8: 453–60

    Article  PubMed  CAS  Google Scholar 

  13. Moser U, Gregor M, Bachofen U, et al. Comparative assessment of renal function in rheumatic patients treated with tenoxicam (20mg daily) or diclofenac (100mg daily). APLAR Congress: 1992 Sept 13–18; Bali, Indonesia

  14. Schardijn GHC, van Eps LWS. β2-microglobulin: its significance in the evaluation of renal function. Kidney Int 1987; 32: 635–41

    Article  PubMed  CAS  Google Scholar 

  15. Ghose K, Burch A. Measurement of renal functions by double isotope techniques in elderly patients during tenoxicam therapy. Arch Gerontol Geriatr 1989; 9: 115–22

    Article  PubMed  CAS  Google Scholar 

  16. Hartmann D, Vetter G, Eckert M. Tenoxicam and renal function in elderly patients. Br J Clin Res 1994; 5: 65–71

    Google Scholar 

  17. Horak E, Hopfer SM, Sundermann FW. Spectrophotometric assay for urinary N-acetyl-β-D-glucosaminidase activity. Clin Chem 1981; 27: 1180–5

    PubMed  CAS  Google Scholar 

  18. Richards IM, Fraser SM, Capell HA. A survey of renal function in out-patients with rheumatoid arthritis. Clin Rheumatol 1988; 7: 267–73

    Article  PubMed  CAS  Google Scholar 

  19. Alfred J, Wong W, Kafetz K. Elderly people taking non-steroidal anti-inflammatory drugs are unlikely to have excess renal impairment. Postgrad Med J 1989; 65: 735

    Article  Google Scholar 

  20. Wolfe SM. Suprofen induced transient flank pain and renal failure. N Engl J Med 1987: 316: 1025

    Article  PubMed  CAS  Google Scholar 

  21. Darwish R, Vaziri ND, Gupta S. Focal renal cortical necrosis associated with zomepirac. Am J Med 1984; 76: 113–7

    Article  Google Scholar 

  22. Richardson CJ, Blocks KLN, Ross SG, et al. Effects of age and sex on Piroxicam disposition. Clin Pharmacol Ther 1985; 37: 13–8

    Article  PubMed  CAS  Google Scholar 

  23. Lang B, Hauck P, Meske S, et al. Die Nierenfunktion unter Therapie mit nicht steroidalen Antiphlogistika. Eine doppelblinde cross-over Studie mit Diclofenac, Indomethacib und Piroxicam. Z Rheumatol 1991; 50: 366–70

    PubMed  CAS  Google Scholar 

  24. Advenier C, Roux A, Gobert C, et al. Pharmacokinetics of ketoprofen in the elderly. Br J Clin Pharmacol 1983; 16: 65–70

    Article  PubMed  CAS  Google Scholar 

  25. Stafanger G, Larsen HW, Hansen H, et al. Pharmacokinetics of ketoprofen in patients with renal impairment. Scand J Rheumatol 1981; 10: 189–92

    Article  PubMed  CAS  Google Scholar 

  26. Greenblatt DJ, Abernethy DR, Matlis R, et al. Absorption and disposition of ibuprofen in the elderly. Arthritis Rheum 1984; 27: 1066–9

    Article  PubMed  CAS  Google Scholar 

  27. Anttila M, Haataja M, Kasanen A. Pharmacokinetics of naproxen in subjects with normal and impaired renal function. Eur J Clin Pharmacol 1980; 18: 263–8

    Article  PubMed  CAS  Google Scholar 

  28. McVerry RM, Lethbridge J, Martin N, et al. Pharmacokinetics of naproxen in elderly patients. Eur J Clin Pharmacol 1986; 31: 463–8

    Article  PubMed  CAS  Google Scholar 

  29. Aronoff GR, Ozawa T, De Sante KA, et al. Benoxaprofen kinetics in renal impairment. Clin Pharmacol Ther 1982; 32: 190–4

    Article  PubMed  CAS  Google Scholar 

  30. Brogard JM, Comte F, Madon M, et al. Pharmacokinetic profile of benoxaprofen in subjects with normal and impaired renal function: plasma level prediction. Curr Ther Res 1981; 30: 161–70

    Google Scholar 

  31. Nilsen OG, Wessel-Aas T, Walseth F. Single dose pharmacokinetics of tiaprofenic acid. Effect of food and severe renal insufficiency. Arzneimittel Forschung 1985; 35: 871–5

    PubMed  CAS  Google Scholar 

  32. Lamy PP. Renal effects of non-steroidal anti-inflammatory drugs. J Am Geriatr Soc 1986; 34: 361–7

    PubMed  CAS  Google Scholar 

  33. Carmichel J, Schankel SW. Effects of non-steroidal anti-inflammatory drugs on prostaglandin and renal function. Am J Med 1985; 78: 992–1000

    Article  Google Scholar 

  34. Whelton A, Stout RL, Spilman PS, et al. Renal effects of ibuprofen, piroxicam and sulindac in patients with asymptomatic renal failure. Ann Intern Med 1990; 112: 568–76

    PubMed  CAS  Google Scholar 

  35. del Favero A. Anti-inflammatory analgesics and drugs used in rheumatoid arthritis and gout. In: Dukes MNG, Beeley L, editors. Side effects of drugs annual. Vol. 12. Amsterdam: Elsevier Science Publishers, 1988: 79–100

    Article  Google Scholar 

  36. del Favero A. Anti-intlammatory analgesics and drugs used in rheumatoid arthritis and gout. In: Dukes MNG, Aronson JK, editors. Side effects of drugs annual. Vol. 16. Amsterdam: Elsevier Science Publishers, 1992: 103–20

    Article  Google Scholar 

  37. Hartmann D, Kleinblösem Ch, Lücker PW, et al. Study on possible interaction between tenoxicam and furosemide. Drug Res 1987; 37: 1072–6

    CAS  Google Scholar 

  38. Heintz RCA. Aspects de la pharmacocinétique du tenoxicam — Tilcotil® — chez l’homme. In: Gaucher A, Pourel J, Netter P, et al., editors. Actualités en Physiopathologie et pharmacologie articulaires. Paris: Masson, 1989

    Google Scholar 

  39. Maiche AG. Acute renal failure due to concomitant action of methotrexate and indomethacin. Lancet 1986; 1(8494): 1390

    Article  PubMed  CAS  Google Scholar 

  40. Rhymer AR. Clinoril (sulindac): a review of effects on renal function and blood pressure. Adv Ther 1985; 2: 293

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, University Louis Pasteur, Strasbourg, France

    Roland C. A. Heintz (Associate Professor in Pharmacokinetics, International Medical Manager)

  2. Faculty of Pharmacy, F. Hoffmann-La Roche Ltd, Basel, Switzerland

    Roland C. A. Heintz (Associate Professor in Pharmacokinetics, International Medical Manager)

Authors
  1. Roland C. A. Heintz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heintz, R.C.A. Tenoxicam and Renal Function. Drug-Safety 12, 110–119 (1995). https://doi.org/10.2165/00002018-199512020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199512020-00004

Keywords

Search

Navigation